开能健康
(300272)
| 流通市值：33.21亿 | | | 总市值：43.72亿 |
| 流通股本：4.64亿 | | | 总股本：6.11亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,355,645,119.71 | 889,329,811.28 | 405,475,102.35 | 1,688,500,855.6 |
| 营业收入 | 1,355,645,119.71 | 889,329,811.28 | 405,475,102.35 | 1,688,500,855.6 |
| 二、营业总成本 | 1,184,357,180.81 | 768,866,157.64 | 355,567,191.64 | 1,520,920,924.29 |
| 营业成本 | 812,640,558.04 | 523,635,412.42 | 238,717,953.09 | 1,030,027,765.54 |
| 税金及附加 | 7,171,997.59 | 4,747,643.34 | 2,895,458.69 | 9,733,187.57 |
| 销售费用 | 134,338,217.39 | 92,457,527.85 | 41,146,634.66 | 182,058,186.29 |
| 管理费用 | 165,619,708.35 | 107,545,072.6 | 55,281,862.91 | 234,685,375.11 |
| 研发费用 | 47,792,071.38 | 30,071,248.79 | 13,595,783.93 | 68,479,784.71 |
| 财务费用 | 16,794,628.06 | 10,409,252.64 | 3,929,498.36 | -4,063,374.93 |
| 其中:利息费用 | 25,597,457.76 | 16,387,687.42 | 7,856,852.94 | 34,481,856.51 |
| 其中:利息收入 | 16,485,859.72 | 10,305,639.59 | 3,484,385.2 | 22,548,261.47 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -32,140.71 | -32,140.71 | -32,140.68 | -3,001,349.41 |
| 加:投资收益 | -33,884,538.95 | -19,403,004.05 | -9,017,868.73 | -30,496,289.09 |
| 资产处置收益 | -30,960.35 | 0 | 0 | -112,753.26 |
| 资产减值损失(新) | -1,292,170.9 | -1,272,871.85 | 23,259.67 | -7,056,956.98 |
| 信用减值损失(新) | 45,487.47 | 53,865.99 | 237,547.44 | -1,412,518.88 |
| 其他收益 | 7,945,921.04 | 5,324,123.81 | 2,168,061.6 | 14,577,541.46 |
| 四、营业利润 | 144,039,536.5 | 105,133,626.83 | 43,286,770.01 | 140,077,605.15 |
| 加:营业外收入 | 36,728 | 8,149.8 | 0.1 | 1,064,689.08 |
| 减:营业外支出 | 906,358.42 | 607,196.57 | 327,642.44 | 6,138,129.86 |
| 五、利润总额 | 143,169,906.08 | 104,534,580.06 | 42,959,127.67 | 135,004,164.37 |
| 减:所得税费用 | 23,718,278.16 | 16,900,087.67 | 9,022,703.02 | 21,555,280.07 |
| 六、净利润 | 119,451,627.92 | 87,634,492.39 | 33,936,424.65 | 113,448,884.3 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 119,451,627.92 | 87,634,492.39 | 33,936,424.65 | 113,448,884.3 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 95,353,246.99 | 70,145,892.58 | 24,810,870.17 | 83,575,721.82 |
| 少数股东损益 | 24,098,380.93 | 17,488,599.81 | 9,125,554.48 | 29,873,162.48 |
| 扣除非经常损益后的净利润 | 91,339,759.9 | 67,550,219.15 | 23,999,192.64 | 76,774,507.32 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.17 | 0.12 | 0.04 | 0.15 |
| (二)稀释每股收益 | 0.17 | 0.12 | 0.04 | 0.14 |
| 八、其他综合收益 | -2,654,457.3 | -653,946.46 | -1,516,723.68 | -185,850.71 |
| 归属于母公司股东的其他综合收益 | -2,308,130.79 | -854,303.94 | -1,291,929.64 | 342,561.9 |
| 九、综合收益总额 | 116,797,170.62 | 86,980,545.93 | 32,419,700.97 | 113,263,033.59 |
| 归属于母公司股东的综合收益总额 | 93,045,116.2 | 69,291,588.64 | 23,518,940.53 | 83,918,283.72 |
| 归属于少数股东的综合收益总额 | 23,752,054.42 | 17,688,957.29 | 8,900,760.44 | 29,344,749.87 |
| 公告日期 | 2025-10-30 | 2025-08-26 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |